by Chandré Blignaut | Feb 8, 2022 | Featured, News
Sanofi partnership strengthens mental health service delivery in South Africa Sanofi South Africa has partnered with the National Department of Health, the Foundation for Professional Development and the World Association of Social Psychiatry to upskill health workers...
by Chandré Blignaut | Sep 20, 2021 | Featured, News
Dupixent® (dupilumab) now available in South Africa for treatment of adult patients with moderate-to-severe atopic dermatitis First targeted biologic in South Africa for use in atopic dermatitis 17 September 2021 – Sanofi has announced that Dupixent® (dupilumab) is...
by Chandré Blignaut | Jun 30, 2021 | Featured, News
Study shows more people on Soliqua® had improved blood sugar control without weight gain and without low blood sugar events (hypoglycaemia) in first head-to-head comparison with premixed insulin These findings come just ahead of Soliqua’s® launch in South Africa...
by Chandré Blignaut | Mar 24, 2021 | Featured, News
Sanofi launches innovative TB prevention treatment set to be a game-changer for South Africa Tuberculosis (TB) remains a major cause of ill health and one of the top 10 causes of death worldwide.1 TB can affect anyone, anywhere – but it is also curable and...
by Chandré Blignaut | Oct 11, 2019 | Featured, Journals, News
Rabies is fatal, but preventable – Be proactive. Johannesburg, 10 October 2019. Between 5 and 30 human rabies cases are confirmed in South Africa every year and more than 70% of these occur in children and teenagers.[1] The rabies virus is transmitted through...
